Showing 7,101 - 7,120 results of 226,904 for search '(( a ((peer decrease) OR (a decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 1.68s Refine Results
  1. 7101
  2. 7102

    A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele-0 by Ryan J Haasl (92283)

    Published 2011
    “…<p><b>Copyright information:</b></p><p>Taken from "A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele"</p><p>http://www.biomedcentral.com/1471-2350/9/37</p><p>BMC Medical Genetics 2008;9():37-37.…”
  3. 7103

    Image4_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    “…<p>Background: The molecular mechanisms of EWS-FLI-mediating target genes and downstream pathways may provide a new way in the targeted therapy of Ewing sarcoma. …”
  4. 7104
  5. 7105

    Table_1_A Common Variant at the 3'untranslated Region of the CCL7 Gene (rs17735770) Is Associated With Decreased Susceptibility to Coronary Heart Disease.pdf by José María Medina-Gil (12692891)

    Published 2022
    “…Propensity score matching analysis, performed to eliminate the influence of these risk factors and highlight genetic modifiers, revealed that a single nucleotide variant, rs17735770 at the 3'untranslated region of the CCL7 gene transcript, was associated with decreased cardiovascular risk in a group represented mostly by men, with an average age of 57, and without significant differences in traditional risk factors. …”
  6. 7106
  7. 7107
  8. 7108
  9. 7109

    Image7_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    “…<p>Background: The molecular mechanisms of EWS-FLI-mediating target genes and downstream pathways may provide a new way in the targeted therapy of Ewing sarcoma. …”
  10. 7110

    Image6_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    “…<p>Background: The molecular mechanisms of EWS-FLI-mediating target genes and downstream pathways may provide a new way in the targeted therapy of Ewing sarcoma. …”
  11. 7111

    JWH-018 and M1 decreased mouse locomotor activity in a CB1R-dependent manner, similar to Δ<sup>9</sup>-THC. by Lisa K. Brents (348607)

    Published 2013
    “…<p><b>A.</b> Intraperitoneal (i.p.) administration of 3 mg/kg JWH-018, 10 mg/kg JWH-018 M1, and 30 mg/kg Δ<sup>9</sup>-THC decreased locomotor activity relative to vehicle controls over a 10 h time course, beginning 60 min after injection. …”
  12. 7112
  13. 7113

    Image2_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    “…<p>Background: The molecular mechanisms of EWS-FLI-mediating target genes and downstream pathways may provide a new way in the targeted therapy of Ewing sarcoma. …”
  14. 7114

    Table2_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.DOCX by Runzhi Huang (7428713)

    Published 2022
    “…<p>Background: The molecular mechanisms of EWS-FLI-mediating target genes and downstream pathways may provide a new way in the targeted therapy of Ewing sarcoma. …”
  15. 7115
  16. 7116

    Image11_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    “…<p>Background: The molecular mechanisms of EWS-FLI-mediating target genes and downstream pathways may provide a new way in the targeted therapy of Ewing sarcoma. …”
  17. 7117
  18. 7118
  19. 7119

    Image3_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    “…<p>Background: The molecular mechanisms of EWS-FLI-mediating target genes and downstream pathways may provide a new way in the targeted therapy of Ewing sarcoma. …”
  20. 7120

    Decreased levels of dCAP-D3/Condensin II result in a local loss of retrotransposon sequence <i>in vivo</i> and <i>in vitro</i>. by Andrew T. Schuster (478446)

    Published 2013
    “…<p>A) PCR performed on DNA from wild type (<i>w<sup>1118</sup></i>) adults and dCAP-D3 transheterozygous mutant adults (d<i>Cap-D3<sup>c07081</sup></i>d<i>Cap-D3<sup>/Δ25</sup></i>) to detect whether three different retrotransposon sequences (<i>mdg1-1403, G2-1077, X-978</i>) were present (P) or absent (A) in dCAP-D3 regulated gene clusters indicates absence of the retrotransposon sequence only in <i>dCap-D3</i> mutants. …”